DaVita Pre-Tax Income 2010-2024 | DVA

DaVita annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • DaVita pre-tax income for the quarter ending September 30, 2024 was $0.373B, a 1.26% decline year-over-year.
  • DaVita pre-tax income for the twelve months ending September 30, 2024 was $1.406B, a 35.75% increase year-over-year.
  • DaVita annual pre-tax income for 2023 was $1.177B, a 21.82% increase from 2022.
  • DaVita annual pre-tax income for 2022 was $0.966B, a 36.37% decline from 2021.
  • DaVita annual pre-tax income for 2021 was $1.518B, a 15.19% increase from 2020.
DaVita Annual Pre-Tax Income
(Millions of US $)
2023 $1,177
2022 $966
2021 $1,518
2020 $1,318
2019 $1,195
2018 $1,048
2017 $1,400
2016 $1,623
2015 $688
2014 $1,310
2013 $1,125
2012 $1,001
2011 $917
2010 $741
2009 $758
DaVita Quarterly Pre-Tax Income
(Millions of US $)
2024-09-30 $373
2024-06-30 $371
2024-03-31 $372
2023-12-31 $289
2023-09-30 $378
2023-06-30 $295
2023-03-31 $215
2022-12-31 $147
2022-09-30 $207
2022-06-30 $349
2022-03-31 $263
2021-12-31 $315
2021-09-30 $394
2021-06-30 $432
2021-03-31 $377
2020-12-31 $327
2020-09-30 $283
2020-06-30 $338
2020-03-31 $369
2019-12-31 $382
2019-09-30 $274
2019-06-30 $324
2019-03-31 $216
2018-12-31 $259
2018-09-30 $167
2018-06-30 $320
2018-03-31 $302
2017-12-31 $47
2017-09-30 $289
2017-06-30 $288
2017-03-31 $776
2016-12-31 $412
2016-09-30 $716
2016-06-30 $229
2016-03-31 $265
2015-12-31 $112
2015-09-30 $408
2015-06-30 $331
2015-03-31 $-162
2014-12-31 $354
2014-09-30 $336
2014-06-30 $282
2014-03-31 $337
2013-12-31 $380
2013-09-30 $271
2013-06-30 $413
2013-03-31 $62
2012-12-31 $282
2012-09-30 $271
2012-06-30 $187
2012-03-31 $261
2011-12-31 $293
2011-09-30 $259
2011-06-30 $187
2011-03-31 $178
2010-12-31 $129
2010-09-30 $218
2010-06-30 $195
2010-03-31 $199
2009-12-31 $194
2009-09-30 $200
2009-06-30 $190
2009-03-31 $173
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.098B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00